The systems that matter most for dementia prevention In longevity medicine, the practical question is not whether one therapy is good for the brain. The better question is whether the persons overall biology is moving toward resilience or vulnerability
This hypothesis is also supported by our HIF-1 knockdown experiments, in which GLP-1R signalling-induced gene expression and metabolic adaptations were only partially perturbed, pointing to a possible involvement of additional transcriptional factors
titrate based on tolerance and BMI
Whether from a GLP-1 drug, a strong diet, or a mix of both, quick weight reduction poses a genuine risk of losing lean muscle mass alongside fat, especially if protein intake and resistance exercise are not given top priority
Therapeutic applications of Dihexa focus on comprehensive cognitive enhancement, memory optimization, learning capacity improvement, age-related cognitive decline prevention, and neurological recovery support